➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
McKesson
Moodys
Express Scripts
Merck

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IVABRADINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Ivabradine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00143507 ↗ The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction Completed Institut de Recherches Internationales Servier Phase 3 2004-12-01 The aim of this study is to test whether ivabradine is able to reduce cardiovascular events when given to patients with coronary artery disease and impaired heart function.
NCT00202566 ↗ Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris Completed Institut de Recherches Internationales Servier Phase 3 2005-06-01 To test whether ivabradine when given in combination with atenolol is able to improve the exercise tolerance of patients with stable angina pectoris
NCT00202579 ↗ Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure Completed Institut de Recherches Internationales Servier Phase 2 2004-09-01 To evaluate the effects on heart function of ivabradine administered to patients with severe chronic heart failure
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ivabradine Hydrochloride

Condition Name

Condition Name for Ivabradine Hydrochloride
Intervention Trials
Heart Failure 11
Coronary Artery Disease 5
Atrial Fibrillation 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Ivabradine Hydrochloride
Intervention Trials
Heart Failure 30
Myocardial Ischemia 11
Coronary Artery Disease 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ivabradine Hydrochloride

Trials by Country

Trials by Country for Ivabradine Hydrochloride
Location Trials
United States 17
China 9
Italy 9
United Kingdom 5
Egypt 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Ivabradine Hydrochloride
Location Trials
Michigan 3
New York 2
Missouri 1
Indiana 1
Illinois 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ivabradine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Ivabradine Hydrochloride
Clinical Trial Phase Trials
Phase 4 30
Phase 3 15
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Ivabradine Hydrochloride
Clinical Trial Phase Trials
Completed 21
Recruiting 19
Not yet recruiting 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ivabradine Hydrochloride

Sponsor Name

Sponsor Name for Ivabradine Hydrochloride
Sponsor Trials
Amgen 5
Institut de Recherches Internationales Servier 4
Second University of Naples 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Ivabradine Hydrochloride
Sponsor Trials
Other 88
Industry 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Medtronic
AstraZeneca
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.